advertisement
11.13.2 Betablocker and carbon anhydrase inhibitor (6)
Showing records 1 to 6
Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor
Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor27353 Choroidal detachment in an elderly patient who was treated post operatively with topical dorzolamide and timolol combination
Anupama B; Puthran N; Hegde V
Journal of Clinical and Diagnostic Research 2010; 4: 3230-3232
27488 Tolerability and effectiveness of preservativefree dorzolamide-timolol (preservative-free COSOPT((registered trademark))) in patients with open-angle glaucoma or ocular hypertension
Hutnik C; Neima D; Ibrahim F; Scott R; Vaillancourt J; Haine D; Sampalis JS; Bastien N; Foucart S
Clinical Ophthalmology 2010; 4: 581-590
27438 Effectiveness of dorzolamide-timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: The COSOPT first-line study
Crichton ACS; Harasymowycz P; Hutnik CML; Behki R; Boucher S; Ibrahim F; Rifkind AW; Solomon L; Liao C; Bastien NR
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 503-511
27246 Brinzolamide 1/timolol 0.5: Safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma
Januleviciene I
Current Medical Research and Opinion 2010; 26: 2575-2578
27287 Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT(trademark)) in patients with elevated intraocular pressure in a randomized clinical trial
Shedden A; Adamsons IA; Getson AJ; Laurence JK; Lines CR; Hewitt DJ; Ho TW
Graefe's Archive for Clinical and Experimental Ophthalmology 2010; 248: 1757-1764
27224 A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients
Jothi R; Ismail AM; Senthamarai R; Pal S
Indian Journal of Pharmacology 2010; 42: 362-365
